Aortic valve replacement

Morton Plant Hospital Performs 1000th TAVR Surgery

Retrieved on: 
Tuesday, June 26, 2018
Cardiac surgery, Medicine, Clinical medicine, Circulatory system, Valve replacement, Aortic stenosis, Percutaneous aortic valve replacement, Aortic valve replacement

TAVR, a minimally invasive heart valve replacement surgery, was originally used for patients with severe aortic stenosis who were not candidates for open heart valve replacement surgery.

Key Points: 
  • TAVR, a minimally invasive heart valve replacement surgery, was originally used for patients with severe aortic stenosis who were not candidates for open heart valve replacement surgery.
  • "Over the past six years, since we performed the first TAVR surgery at Morton Plant Hospital, we have given hope to countless individuals suffering from severe aortic stenosis who had no other hope for an improved quality of life."
  • If surgery is needed, the St. Anthony's clinic will help patients through that process and surgical procedures will be performed at Morton Plant Hospital.
  • Morton Plant Hospital offers innovative, accessible, and quality services to provide our community with a lifetime of compassionate, convenient care.

Minimizing the Risk of Repairing a Broken Heart

Retrieved on: 
Monday, June 25, 2018
Medicine, Surgery, Clinical medicine, Cardiac surgery, Surgical specialties, Interventional cardiology, Aortic valve, Heart valve, Cardiothoracic surgery, Percutaneous aortic valve replacement, Aortic valve replacement

Over time, Gorham's aortic valve had thickened, resulting in a narrowing of the opening and restricted blood flow from the heart.

Key Points: 
  • Over time, Gorham's aortic valve had thickened, resulting in a narrowing of the opening and restricted blood flow from the heart.
  • Due to Gorham's age, traditional open heart surgery to replace the faulty valve could be risky.
  • Transcatheter techniques like those used in TAVR are performed while the patient's heart is still beating, eliminating the need for a "bypass" machine and its associated risks during open heart surgery.
  • The team is composed of an interventional cardiologist, cardiac surgeon, a cardiac imaging specialist, valve clinic coordinator, structural heart nurse and a structural heart nurse practitioner.

CryoLife Announces Peer Review Publication of On-X® Aortic Heart Valve PROACT Study

Retrieved on: 
Monday, June 11, 2018
Cardiac surgery, Medicine, Clinical medicine, Aortic valve replacement, Artificial heart valve, Aortic valve, Valve replacement, Warfarin, CryoLife, Aortic valve repair, Pericardial heart valves

ATLANTA, June 11, 2018 /PRNewswire/ --CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, today announces the publication of our clinical study entitled "Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement" in a peer-reviewed medical journal, the Journal of the American College of Cardiology.

Key Points: 
  • ATLANTA, June 11, 2018 /PRNewswire/ --CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, today announces the publication of our clinical study entitled "Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement" in a peer-reviewed medical journal, the Journal of the American College of Cardiology.
  • We consider the On-X valve to be state-of-the-art for aortic valve replacement as it offers a one-time surgical solution with proven low gradients, resistance to pannus formation, and outstanding durability."
  • Since antiplatelet strategies were unsuccessful in this study group, warfarin is still required with mechanical valves, but with a lower-intensity INR for the On-X mechanical aortic valve as shown by the results for the High Risk study group.
  • These key features translate into laminar flow, low gradients, and reduced thrombogenicity making it the most clinically beneficial lifelong heart valve replacement option available for patients today.

Global Transcatheter Aortic Valve Replacement (Transfemoral and Transapical) Market Report 2018

Retrieved on: 
Wednesday, May 30, 2018
Medicine, Cardiac surgery, Clinical medicine, Circulatory system, Percutaneous aortic valve replacement, Cardiology, Aortic valve replacement, Aortic valve, Valve replacement, Interventional cardiology, Heart valve, John G. Webb

The "Global Transcatheter Aortic Valve Replacement (TAVR) Market (Value, Volume): Analysis By Type of Approach (Transfemoral, Transapical), By Region, By Country (2018 Edition): Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Transcatheter Aortic Valve Replacement (TAVR) Market (Value, Volume): Analysis By Type of Approach (Transfemoral, Transapical), By Region, By Country (2018 Edition): Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
  • Transcatheter aortic valve replacement has been a ground-breaking advancement in the field of interventional cardiology and cardiovascular surgery.
  • Amongst the regions, North America accounts for the largest regional share in the global transcatheter aortic valve replacement market in 2018.
  • Global Transcatheter Aortic Valve Replacement (TAVR) Market(Actual Period: 2013-2017, Forecast Period: 2018-2023)
    Transcatheter Aortic Valve Replacement (TAVR) Market - Size and Growth: By Value, By Volume.